CH5132799

CH5132799 is a new class I PI3K inhibitor, especially showing strong inhibitory activity against PI3Kα. CH5132799 displays potent antiproliferative activity in human tumor cell lines with PI3K pathway activation. CH5132799 is orally available and demonstrated significant antitumor activity in a xenograft mouse model of human cancer with PI3K pathway activation.
Supplier Alfa Cytology
Product # BC0134
Pricing 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, inquire
Feedback